Clinically relevant acute subjective effects of psychedelics beyond mystical experience
Nature Reviews Psychology September 3, 2024 David B. Yaden, Sean P. Goldy, Brandon Weiss et al. 57 citations
No Summary
2 papers in the library · 58 citations · publishing 2024-2026
Nature Reviews Psychology September 3, 2024 David B. Yaden, Sean P. Goldy, Brandon Weiss et al. 57 citations
No Summary
Psychiatry Research February 13, 2026 Sean P. Goldy, Nathan D. Sepeda, Samantha Hilbert et al. 1 citation
The acute subjective effects of psychedelics are known to predict therapeutic benefits like reduced depression and anxiety. Session facilitators—who support participants before, during, and after dosing—are a key part of the setting, but their influence on subjective effects was unclear. Analyzing data from 9 psilocybin studies with 298 participants, 670 sessions, and 60 facilitators, multilevel models showed facilitators accounted for negligible variance (0.8%) in healthy volunteers but greater variance in clinical samples (13.6%), after controlling for study and participant differences. This suggests facilitators may play a clinically meaningful role in shaping outcomes for patient populations, comparable to or exceeding therapist effects in traditional psychotherapy (~8%).